Enrichment for metallothionein does not confer resistance to cisplatin in transfected NIH/3T3 cells.

MLA

Morton, K. A., et al. “Enrichment for Metallothionein Does Not Confer Resistance to Cisplatin in Transfected NIH/3T3 Cells.” The Journal of Pharmacology and Experimental Therapeutics, vol. 267, no. 2, Nov. 1993, pp. 697–702. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs29421987&authtype=sso&custid=ns315887.

APA

Morton, K. A., Jones, B. J., Sohn, M. H., Datz, F. L., & Lynch, R. E. (1993). Enrichment for metallothionein does not confer resistance to cisplatin in transfected NIH/3T3 cells. The Journal of Pharmacology and Experimental Therapeutics, 267(2), 697–702.

Chicago

Morton, K A, B J Jones, M H Sohn, F L Datz, and R E Lynch. 1993. “Enrichment for Metallothionein Does Not Confer Resistance to Cisplatin in Transfected NIH/3T3 Cells.” The Journal of Pharmacology and Experimental Therapeutics 267 (2): 697–702. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs29421987&authtype=sso&custid=ns315887.